On the eve of the second trial over its painkiller Vioxx, drug giant Merck said Friday it will fight the mounting lawsuits over the withdrawn drug, despite recently saying it might settle some suits. Merck's general counsel and senior vice president also tried to reassure investors that liability over Vioxx, estimated by analysts at up to $50 billion, isn't a threat to the New Jersey company. Also on Friday, the Superior Court judge who will hear the case ruled that TV cameras will be allowed in court.
September 12, 2005 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
On the eve of the second trial over its painkiller Vioxx, drug giant Merck & Co. on Friday reasserted that it plans to aggressively fight the mounting lawsuits over the withdrawn drug, despite recently saying it might settle some suits.
Kenneth C. Frazier, Merck’s general counsel and senior vice president, also tried to reassure investors that liability over Vioxx — estimated by analysts at up to $50 billion — isn’t a threat to the Whitehouse Station, N.J.-based company.
Presented by BigVoodoo
This conference aims to help insurers and litigators better manage complex claims and litigation.
Recognizing innovation in the legal technology sector for working on precedent-setting, game-changing projects and initiatives.
Legalweek New York explores Business and Regulatory Trends, Technology and Talent drivers impacting law firms.
McCarter & English is actively seeking a 5th-6th year trademark associate who has trademark prosecution, licensing and litigation experi...
**PLEASE READ THE COMPLETE AD BEFORE APPLYING***Established 25-year boutique Plaintiff's Personal Injury Law Firm in the Dadeland area seeki...
Our client, a multi-state full-service boutique, is seeking to add a senior construction litigation associate to their Florida team. Qualif...
